
A merger of US grains merchant Bunge with rival Viterra would grow the combined entity’s businesses in the US, Brazil and Australia and may raise competition concerns in parts of Canada and Argentina, where key oilseed processing assets overlap, analysts said.
Sources last week said Bunge and Glencore Plc-owned Viterra were in talks for a potential mega deal that would further consolidate global agriculture trading and bring Bunge closer in global scale to leading rivals Archer-Daniels-Midland and Cargill, reported Reuters.
Read more: EU Invites Comments On Draft Guidelines For Sustainability Agreements In Agriculture
“Combining Bunge and Viterra in regions like North America and Europe certainly would strengthen the combined company’s presence there and put them more on par with ADM,” said Seth Goldstein, equity analyst with Morningstar.
“Bunge is already the leader in South America. That might be a region where there might be some divestitures required if a deal were to close there to make sure that there’s still competition,” he added.
According to J.P. Morgan equity research, the market capitalization of the combined company is estimated to be approximately $25 billion, in comparison to ADM’s current market cap of $38.9 billion.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas